Toward a Feminist Critical Pedagogy in a Beginning Japanese-as-a-Foreign-Language Class

Yumiko Ohara,Scott Saft,G. Crookes

DOI: https://doi.org/10.2307/489693

2001-10-01

Abstract:

What problem does this paper attempt to address?

Evaluation and Target Validation of Indole Derivatives As Inhibitors of the AcrAB-TolC Efflux Pump.

Bo Zeng,Hongning Wang,Likou Zou,Anyun Zhang,Xin Yang,Zhongbin Guan

DOI: https://doi.org/10.1271/bbb.100433

2010-01-01

Abstract:Indole derivatives 3-amino-6-carboxyl-indole and 3-nitro-6-amino-indole were designed and synthesized based on the TolC structure. They proved to have potent synergistic antibacterial effects on chloramphenicol, tetracycline, erythromycin, and ciprofloxacin against Escherichia coli YD2 and FJ307 with decreased minimal inhibitory concentrations (MICs) at 2-64 folds. To research its functional site, Escherichia coli BL21(DE3)-3 expressing a target-site mutated TolC was constructed by red homologous recombination and the site-directed mutagenesis technique. They did not noticeably affect antimicrobial activity against BL21(DE3)-3. All the results indicate that these compounds match our design and can be developed as efflux pump inhibitors for the AcrAB-TolC efflux pump.
Elucidating TolC Protein Dynamics: Structural Shifts Facilitate Efflux Mediated β-lactam Resistance

Isik Kantarcioglu,Ilona K. Gaszek,Tandac F. Guclu,M. Sadik Yildiz,Ali Rana Atilgan,Erdal Toprak,Canan Atilgan

DOI: https://doi.org/10.1101/2024.02.22.581573

2024-02-23

Abstract:Efflux-mediated β-lactam resistance represents a significant public health challenge, limiting the efficacy of various β-lactam antibiotics against numerous clinically relevant pathogenic bacteria. Structural and functional analyses have revealed that the efflux protein TolC in several Gram-negative bacteria serves as a conduit for antibiotics, bacteriocins, and phages, affecting bacterial susceptibility and virulence. In this study, we conducted a comprehensive examination of the efflux of β-lactam drugs mediated by TolC, employing extensive experimental and computational analyses. Our computational investigations into the molecular dynamics of drug-free TolC revealed critical unidirectional movements of the trimeric TolC and identified residues significantly involved in TolC opening. To corroborate these findings, we performed a whole-gene-saturation mutagenesis assay, systematically mutating each residue of TolC to 19 other amino acids and measuring the fitness effects of these mutations under β-lactam-induced selection. The β-lactams oxacillin, piperacillin, and carbenicillin were selected for this study because they are effluxed by the AcrAB-TolC complex with varying efficiencies. This approach clarified the similarities and differences in the efflux processes of the three β-lactam antibiotics through the trimeric TolC. Further analysis of TolC’s efflux mechanism for these β-lactam antibiotics via steered molecular dynamics simulations revealed the existence of general and drug-specific mechanisms employed by TolC. We identified key positions at the periplasmic entry of TolC whose altered dynamics influence long-range efflux motions as allosteric modulators. Our findings provide valuable insights into the structural dynamics of TolC, establishing a foundation for understanding the key mechanisms behind multidrug resistance and principles for designing new antibiotics and antibiotic derivatives capable of circumventing the bacterial efflux mechanism.

Biophysics
Physiological Effects of TolC‐Dependent Multidrug Efflux Pumps in Escherichia coli: Impact on Motility and Growth Under Stress Conditions

Amanda M. Di Maso,Cristian Ruiz

DOI: https://doi.org/10.1002/mbo3.70006

2024-11-13

MicrobiologyOpen

Abstract:The eight TolC‐dependent multidrug efflux pumps of Escherichia coli confer resistance to antibiotics. We report that while individual TolC‐dependent pumps are dispensable for growth under many stress conditions in the absence of antimicrobials, possibly due to their partially overlapping substrate profiles, TolC‐dependent efflux is required for maximal growth under most conditions. Enterobacteriaceae possess eight TolC‐dependent multidrug efflux pumps: AcrAB‐TolC, AcrAD‐TolC, AcrEF‐TolC, MdtEF‐TolC, MdtABC‐TolC, EmrAB‐TolC, EmrYK‐TolC, and MacAB‐TolC, which efflux bile salts, antibiotics, metabolites, or other compounds. However, our understanding of their physiological roles remains limited, especially for less‐studied pumps like EmrYK‐TolC. In this study, we tested the effects on swimming motility and growth under stress conditions of Escherichia coli mutants individually deleted for each inner‐membrane transporter component of all eight TolC‐dependent pumps, a mutant deleted for the AcrB‐accessory protein AcrZ, and a mutant simultaneously deleted for all eight pumps (ΔtolC). We found that all mutants tested, except the ΔemrY and ΔacrZ mutants, displayed increased swimming motility. Additionally, the loss of each individual TolC‐dependent pump or AcrZ did not reduce growth and sometimes even enhanced it compared to the parental strain under various growth conditions: temperature (LB at 25, 30, 37, and 42°C), pH (LB at pH 6.0, 7.4, and 9.0; and LB buffered to pH 6.0, 7.4, and 8.25), LB with limited air exchange, and nutritional stress (M9‐glucose or M9‐glycerol). In contrast, the ΔtolC mutant grew significantly slower than the parental strain under all conditions tested except in LB‐TRIS pH 7.4 and LB with limited air exchange. Overall, these findings indicate that while individual TolC‐dependent pumps are generally dispensable for growth under many stress conditions in the absence of antimicrobials, possibly due to their partially overlapping substrate profiles, TolC‐dependent efflux is required for maximal growth under most conditions.

microbiology
AcrA suppressor alterations reverse the drug hypersensitivity phenotype of a TolC mutant by inducing TolC aperture opening

Jon W Weeks,Teresa Celaya-Kolb,Sara Pecora,Rajeev Misra

DOI: https://doi.org/10.1111/j.1365-2958.2010.07068.x

Abstract:In Escherichia coli, the TolC-AcrAB complex forms a major antibiotic efflux system with broad substrate specificity. During the complex assembly, the periplasmic helices and bottom turns of TolC are thought to interact with a hairpin helix of AcrA and hairpin loops of AcrB respectively. In the present study we show that a four-residue substitution in TolC's turn 1, which connects outer helices 3 and 4 proximal to TolC's periplasmic aperture, confers antibiotic hypersensitivity, without affecting TolC-mediated phage or colicin infection. However, despite the null-like drug sensitivity phenotype, chemical cross-linking analysis revealed no apparent defects in the ability of the mutant TolC protein to physically interact with AcrA and AcrB. A role for TolC turn 1 residues in the functional assembly of the tripartite efflux pump complex was uncovered through isolating suppressor mutations of the mutant TolC protein that mapped within acrA and by utilizing a labile AcrA protein. The data showed that AcrA-mediated suppression of antibiotic sensitivity was achieved by dilating the TolC aperture/channel in an AcrB-dependent manner. The results underscore the importance of the periplasmic turn 1 of TolC in the functional assembly of the tripartite efflux complex and AcrA in transitioning TolC from its closed to open state.
Tigecycline Susceptibility And The Role Of Efflux Pumps In Tigecycline Resistance In Kpc-Producing Klebsiella Pneumoniae

Fang He,Ying Fu,Qiong Chen,Zhi Ruan,Xiaoting Hua,Hua Zhou,Yunsong Yu

DOI: https://doi.org/10.1371/journal.pone.0119064

IF: 3.7

2015-01-01

PLoS ONE

Abstract:KPC-producing Klebsiella pneumoniae isolates have emerged as important pathogens of nosocomial infections, and tigecycline is one of the antibiotics recommended for severe infections caused by KPC-producing K. pneumoniae. To identify the susceptibility profile of KPC-producing K. pneumoniae to tigecycline and investigate the role of efflux pumps in tigecycline resistance, a total of 215 KPC-producing K. pneumoniae isolates were collected. The minimum inhibitory concentration (MIC) of tigecycline was determined by standard broth microdilution tests. Isolates showing resistance to tigecycline underwent susceptibility test with efflux pump inhibitors. Expression levels of efflux pump genes (acrB and oqxB) and their regulators (ramA, marA, soxS and rarA) were examined by real-time PCR, and the correlation between tigecycline MICs and gene expression levels were analysed. Our results show that the tigecycline resistance rate in these isolates was 11.2%. Exposure of the tigecycline-resistant isolates to the efflux pump inhibitor NMP resulted in an obvious decrease in MICs and restored susceptibility to tigecycline in 91.7% of the isolates. A statistically significant association between acrB expression and tigecycline MICs was observed, and overexpression of ramA was found in three tigecycline-resistant isolates, further analysis confirmed ramRmutations existed in these isolates. Transformation of one mutant with wild-type ramR restored susceptibility to tigecycline and repressed overexpression of ramA and acrB. These data indicate that efflux pump AcrAB, which can be up-regulated by ramR mutations and subsequent ramA activation, contributed to tigecycline resistance in K. pneumoniae clinical isolates.
The Antibiotic Efflux Protein TolC Is a Highly Evolvable Target under Colicin E1 or TLS Phage Selection

Yusuf Talha Tamer,Ilona Gaszek,Marinelle Rodrigues,Fatma Sevde Coskun,Michael Farid,Andrew Y Koh,William Russ,Erdal Toprak

DOI: https://doi.org/10.1093/molbev/msab190

2021-09-27

Abstract:Bacteriophages and bacterial toxins are promising antibacterial agents to treat infections caused by multidrug-resistant (MDR) bacteria. In fact, bacteriophages have recently been successfully used to treat life-threatening infections caused by MDR bacteria (Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, et al. 2017. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother. 61(10); Chan BK, Turner PE, Kim S, Mojibian HR, Elefteriades JA, Narayan D. 2018. Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evol Med Public Health. 2018(1):60-66; Petrovic Fabijan A, Lin RCY, Ho J, Maddocks S, Ben Zakour NL, Iredell JR, Westmead Bacteriophage Therapy Team. 2020. Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat Microbiol. 5(3):465-472). One potential problem with using these antibacterial agents is the evolution of resistance against them in the long term. Here, we studied the fitness landscape of the Escherichia coli TolC protein, an outer membrane efflux protein that is exploited by a pore forming toxin called colicin E1 and by TLS phage (Pagie L, Hogeweg P. 1999. Colicin diversity: a result of eco-evolutionary dynamics. J Theor Biol. 196(2):251-261; Andersen C, Hughes C, Koronakis V. 2000. Chunnel vision. Export and efflux through bacterial channel-tunnels. EMBO Rep. 1(4):313-318; Koronakis V, Andersen C, Hughes C. 2001. Channel-tunnels. Curr Opin Struct Biol. 11(4):403-407; Czaran TL, Hoekstra RF, Pagie L. 2002. Chemical warfare between microbes promotes biodiversity. Proc Natl Acad Sci U S A. 99(2):786-790; Cascales E, Buchanan SK, Duché D, Kleanthous C, Lloubès R, Postle K, Riley M, Slatin S, Cavard D. 2007. Colicin biology. Microbiol Mol Biol Rev. 71(1):158-229). By systematically assessing the distribution of fitness effects of ∼9,000 single amino acid replacements in TolC using either positive (antibiotics and bile salts) or negative (colicin E1 and TLS phage) selection pressures, we quantified evolvability of the TolC. We demonstrated that the TolC is highly optimized for the efflux of antibiotics and bile salts. In contrast, under colicin E1 and TLS phage selection, TolC sequence is very sensitive to mutations. Finally, we have identified a large set of mutations in TolC that increase resistance of E. coli against colicin E1 or TLS phage without changing antibiotic susceptibility of bacterial cells. Our findings suggest that TolC is a highly evolvable target under negative selection which may limit the potential clinical use of bacteriophages and bacterial toxins if evolutionary aspects are not taken into account.
Structural shifts in TolC facilitate Efflux-Mediated β-lactam resistance

Isik Kantarcioglu,Ilona K. Gaszek,Tandac F. Guclu,M. Sadik Yildiz,Ali Rana Atilgan,Erdal Toprak,Canan Atilgan

DOI: https://doi.org/10.1038/s42003-024-06750-0

IF: 6.548

2024-08-28

Communications Biology

Abstract:Efflux-mediated β-lactam resistance is a major public health concern, reducing the effectiveness of β-lactam antibiotics against many bacteria. Structural analyses show the efflux protein TolC in Gram-negative bacteria acts as a channel for antibiotics, impacting bacterial susceptibility and virulence. This study examines β-lactam drug efflux mediated by TolC using experimental and computational methods. Molecular dynamics simulations of drug-free TolC reveal essential movements and key residues involved in TolC opening. A whole-gene-saturation mutagenesis assay, mutating each TolC residue and measuring fitness effects under β-lactam selection, is performed. Here we show the TolC-mediated efflux of three antibiotics: oxacillin, piperacillin, and carbenicillin. Steered molecular dynamics simulations identify general and drug-specific efflux mechanisms, revealing key positions at TolC's periplasmic entry affecting efflux motions. Our findings provide insights into TolC's structural dynamics, aiding the design of new antibiotics to overcome bacterial efflux mechanisms.

biology
Efflux Pump AcrAB Confers Decreased Susceptibility to Piperacillin-Tazobactam and Ceftolozane-Tazobactam in Tigecycline-Non-Susceptible Klebsiella Pneumoniae

Junjie Li,Qingqing Xu,Sean Ogurek,Ziqiang Li,Peiyun Wang,Qing Xie,Zike Sheng,Minggui Wang

DOI: https://doi.org/10.2147/idr.s279020

2020-01-01

Infection and Drug Resistance

Abstract:Introduction: Drug efflux pumps are critical for resistance in Gram-negative organisms, but there are limited data on the role they play in decreased susceptibility to beta-lactam/beta-lactamase inhibitor combinations. In this study, we aimed to investigate the impact of efflux pump AcrAB on piperacillin-tazobactam (TZP) and ceftolozane-tazobactam (C/T) susceptibility in tigecycline-non-susceptible Klebsiella pneumoniae (TNSKP) strains. Methods: A tigecycline gradient was used to obtain various TNSKP strains, and in conjunction with the gradient derived strains, a TNSKP clinical strain (TNSKP24) was also included. Minimum inhibitory concentrations (MICs) of antibiotics were determined by the broth microdilution method, and whole-genome sequencing (WGS) was carried out to analyze genomic changes. PCR and sequencing were performed to confirm mutations in ramR, acrR, and the intergenic region of ramR-romA, and qRT-PCR was applied to evaluate levels of gene expression. In-frame acrB knockout and complementation were performed in 3 TNSKP strains. Results: Two derivatives of K. pneumoniae K2606 (K2606-4 and K2606-16) and TNSKP24 overexpressed efflux pump AcrAB were obtained for further study. The MICs of TZP and C/T exhibited a 4-to 8-fold increase in K2606-4 and K2606-16, respectively, when compared with K2606 (TZP, 2/4 mu g/mL; C/T, 0.25/4 mu g/mL). Deletion of acrB decreased the MICs of TZP and C/T by 4-to 16-fold in TNSKP24, K2606-4, and K2606-16, respectively, and complementation of acrB increased the MICs of these agents. MICs of clavulanate, sulbactam, and avibactam in the presence of beta-lactam compounds did not change after acrB deletion and subsequent introduction of complementation mutants. Conclusion: This study highlights that decreased susceptibility to TZP and C/T could be caused by the multidrug efflux pump AcrAB in TNSKP strains.
Escherichia coli resistance mechanism AcrAB-TolC efflux pump interactions with commonly used antibiotics: a molecular dynamics study

Brooke L. Smith,Sandun Fernando,Maria D. King

DOI: https://doi.org/10.1038/s41598-024-52536-z

IF: 4.6

2024-02-01

Scientific Reports

Abstract:Abstract While antibiotic resistance poses a threat from both Gram-positive bacteria (GPB) and Gram-negative bacteria (GNB), GNB pose a more imminent public health hazard globally. GNB are a threat to growing antibiotic resistance because of the complex makeup of the membrane. The AcrAB-TolC efflux pump is a known resistance mechanism of Escherichia coli (E. coli) cells. This study utilized molecular dynamics modeling to visualize some of the changes occurring at a molecular level when airborne bacteria are exposed to stress and antibiotics. This study was conducted to build upon previous experimental research showing that there is an increase in antibiotic resistance and efflux pump activity when exposed to aerosolization. AcrB and AcrAB-TolC proteins were simulated under standard and increased pressure to compare the effect of aerosolization on the binding to the three different antibiotics (puromycin (PUY), ampicillin (AMP) and sulfamethoxazole-trimethoprim (SXT)) to the AcrB binding site. Analysis such as root-mean-square deviation of atomic positions and root-mean-square fluctuation, the opening of TolC, and the significant molecular mechanics with generalized Born and surface area solvation (MM-GBSA) scores associated with specific ligands were recorded. Resistance in experimental data indicated a relationship between the docking scores and some ligand–protein interactions. Results showed that there was more flexibility in the proteins within simulations conducted under standard pressure for the AcrB protein and the full tripartite complex AcrAB-TolC, showing that increased pressure causes more rigidity. MM-GBSA scores, used to calculate the free energy of ligand–protein binding, did not show a significant change, but interestingly, the strongest MM-GBSA scores were for ligands that moved to another binding pocket and did not result in resistance or opening of the efflux pump. However, the ligand moved from the binding site and did not cause the opening of TolC to increase significantly, whereas PUY and AMP were bound to the binding site for the duration of all simulations. AMP ligands under increased pressure showed the largest change in opening of the TolC efflux pump and aligns with experimental data showing E. coli cells had the most resistance to AMP after aerosolization. These results, in addition to other real-time changes such as OM proteins and mutations of targets within the cell, could be used to delineate and mitigate antibiotic resistance mechanisms.

multidisciplinary sciences
Functional characterization of two TolC in the resistance to drugs and metals and in the virulence of Riemerella anatipestifer

Li Huang,Fang Guo,Xiao Li,Mengying Wang,Dekang Zhu,Mingshu Wang,Renyong Jia,Shun Chen,Xinxin Zhao,Shaqiu Zhang,Qun Gao,Qiao Yang,Ying Wu,Juan Huang,Bin Tian,Xumin Ou,Di Sun,Sai Mao,Ling Zhang,YanLing Yu,Friedrich Götz,Anchun Cheng,Mafeng Liu

DOI: https://doi.org/10.1128/aem.01308-23

2023-12-21

Applied and Environmental Microbiology

Abstract:ABSTRACT TolC is an outer membrane protein that is responsible for the efflux of multi-substrates in Gram-negative bacteria. Riemerella anatipestifer CH-1 encodes two TolC proteins, B739_0871 (TolCA) and B739_1784 (TolCB). TolCB was previously involved in the export of manganese (Mn). However, whether TolCB has other substrates is unclear, and the functions of TolCA remain to be characterized. Here, we show that deletion of tolCA renders the bacteria hypersensitive to the gentamicin, the SDS, and various metals, such as Mn(II), Zn(II), Cu(II), Fe(II), Co(II), and Ni(II). By contrast, the deletion of tolCB only conferred high sensitivity to Mn. Consistently, the deletion of tolCA led to intracellular accumulation of the various tested metals, while the deletion of tolCB only led to Mn accumulation under conditions of excess Mn. Moreover, the tolCA deletion mutant (∆ tolCA ) but not the tolCB deletion mutant (∆ tolCB ) was more sensitive to the NaOCl than the wild type (WT). Strikingly, the ∆ tolCA but not ∆ tolCB decreased the frequency of clones resistant to several tested antibiotics. In the duck infection model, the ∆ tolCA but not ∆ tolCB decreased virulence and colonization of R. anatipestifer CH-1, possibly due to increased sensitivity of ∆ tolCA to non-inactivated duck serum as compared to the WT. Finally, genome mining revealed that homologs of tolCA and tolCB are highly conserved across R. anatipestifer strains and also present in other members of Flavobacteriaceae . Taken together, our results revealed that compared with TolCB, TolCA has a wider range of efflux substrates and functions in R. anatipestifer CH-1. IMPORTANCE Riemerella anatipestifer (RA) is a notorious duck pathogen, characterized by a multitude of serotypes that exhibit no cross-reaction with one another. Moreover, RA is resistant to various antibacterial agents. Consequently, understanding the mechanisms behind resistance and identifying potential targets for drug development have become pressing needs. In this study, we show that the two TolC proteins play a role in the resistance to different drugs and metals and in the virulence. The results suggest that TolCA has a wider range of efflux substrates than TolCB. Except for gentamicin, neither TolCA nor TolCB was involved in the efflux of the other tested antibiotics. Strikingly, TolCA but not TolCB enhanced the frequency of resistance-conferring mutations. Moreover, TolCA was involved in RA virulence. Given its conservation in RA, TolCA has potential as a drug target for the development of therapeutics against RA infections.

microbiology,biotechnology & applied microbiology
Structures and Efflux Mechanisms of the AcrAB-TolC Pump

Zhili Yu,Xiaodong Shi,Zhao Wang

DOI: https://doi.org/10.1007/978-3-031-58843-3_1

Abstract:The global emergence of multidrug resistance (MDR) in gram-negative bacteria has become a matter of worldwide concern. MDR in these pathogens is closely linked to the overexpression of certain efflux pumps, particularly the resistance-nodulation-cell division (RND) efflux pumps. Inhibition of these pumps presents an attractive and promising strategy to combat antibiotic resistance, as the efflux pump inhibitors can effectively restore the potency of existing antibiotics. AcrAB-TolC is one well-studied RND efflux pump, which transports a variety of substrates, therefore providing resistance to a broad spectrum of antibiotics. To develop effective pump inhibitors, a comprehensive understanding of the structural aspect of the AcrAB-TolC efflux pump is imperative. Previous studies on this pump's structure have been limited to individual components or in vitro determination of fully assembled pumps. Recent advancements in cellular cryo-electron tomography (cryo-ET) have provided novel insights into this pump's assembly and functional mechanism within its native cell membrane environment. Here, we present a summary of the structural data regarding the AcrAB-TolC efflux pump, shedding light on its assembly pathway and operational mechanism.
Structure of the AcrAB–TolC Multidrug Efflux Pump

Dijun Du,Zhao Wang,Nathan R. James,Jarrod E. Voss,Ewa Klimont,Thelma Ohene-Agyei,Henrietta Venter,Wah Chiu,Ben F. Luisi

DOI: https://doi.org/10.1038/nature13205

IF: 64.8

2014-01-01

Nature

Abstract:The capacity of numerous bacterial species to tolerate antibiotics and other toxic compounds arises in part from the activity of energy-dependent transporters. In Gram-negative bacteria, many of these transporters form multicomponent 'pumps' that span both inner and outer membranes and are driven energetically by a primary or secondary transporter component. A model system for such a pump is the acridine resistance complex of Escherichia coli. This pump assembly comprises the outer-membrane channel TolC, the secondary transporter AcrB located in the inner membrane, and the periplasmic AcrA, which bridges these two integral membrane proteins. The AcrAB-TolC efflux pump is able to transport vectorially a diverse array of compounds with little chemical similarity, thus conferring resistance to a broad spectrum of antibiotics. Homologous complexes are found in many Gram-negative species, including in animal and plant pathogens. Crystal structures are available for the individual components of the pump and have provided insights into substrate recognition, energy coupling and the transduction of conformational changes associated with the transport process. However, how the subunits are organized in the pump, their stoichiometry and the details of their interactions are not known. Here we present the pseudo-atomic structure of a complete multidrug efflux pump in complex with a modulatory protein partner from E. coli. The model defines the quaternary organization of the pump, identifies key domain interactions, and suggests a cooperative process for channel assembly and opening. These findings illuminate the basis for drug resistance in numerous pathogenic bacterial species.
Required criteria of drug efflux pump inhibitors to disrupt the function of AcrB subunit protein from AcrAB-TolC multidrug efflux pump from Escherichia coli

Rawaf Alenazy

DOI: https://doi.org/10.1016/j.jksus.2024.103116

IF: 3.829

2024-02-03

Journal of King Saud University - Science

Abstract:The infections of multidrug-resistant bacteria, particularly the infections caused by Gram-negative bacterial infections, are considered the main global serious health problems. Multidrug-resistant bacteria possess different resistance mechanisms, the most important of which are drug efflux pumps due to their function in recognizing harmful compounds, especially antibiotics, and expelling, them outside the cell, which leads to a decrease in their concentration to sub-toxic levels and losing their effectiveness. One of the most important approaches that can be used to inhibit drug efflux pumps is using small molecule inhibitors targeting specifically pumps to prevent their expelling antibiotics from inside the cell before reaching the required concentration that kills bacteria. The drug efflux pumps inhibition approach is emerging as a new attractive and promising approach in reversing antibiotic resistance in many clinically relevant pathogenic bacteria. This review will discuss the requirements that must be met in inhibitors that target AcrB, which is the main subunit protein responsible for multiple antibiotic resistance in the main pump of AcrAB-TolC which belongs to E. coli, which were specifically chosen due to their various homologs in many Gram-negative bacteria which all of which are implicated in multi-drug resistance (MDR), and the availability of the pump's functions and chemical structures.

multidisciplinary sciences
In situ structure of the AcrAB-TolC efflux pump at subnanometer resolution

Muyuan Chen,Xiaodong Shi,Zhili Yu,Guizhen Fan,Irina I Serysheva,Matthew L Baker,Ben F Luisi,Steven J Ludtke,Zhao Wang,Irina I. Serysheva,Matthew L. Baker,Ben F. Luisi,Steven J. Ludtke

DOI: https://doi.org/10.1016/j.str.2021.08.008

IF: 5.871

2022-01-01

Structure

Abstract:SummaryThe tripartite AcrAB-TolC assembly, which spans both the inner and outer membranes in Gram-negative bacteria, is an efflux pump that contributes to multidrug resistance. Here, we present the in situ structure of full-length Escherichia coli AcrAB-TolC determined at 7 Å resolution by electron cryo-tomography. The TolC channel penetrates the outer membrane bilayer through to the outer leaflet and exhibits two different configurations that differ by a 60° rotation relative to the AcrB position in the pump assembly. AcrA protomers interact directly with the inner membrane and with AcrB via an interface located in proximity to the AcrB ligand-binding pocket. Our structural analysis suggests that these AcrA-bridged interactions underlie an allosteric mechanism for transmitting drug-evoked signals from AcrB to the TolC channel within the pump. Our study demonstrates the power of in situ electron cryo-tomography, which permits critical insights into the function of bacterial efflux pumps.

cell biology,biochemistry & molecular biology,biophysics
The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes

Elizabeth Pradel,Jean-Marie Pagès

DOI: https://doi.org/10.1128/AAC.46.8.2640-2643.2002

Abstract:We identified the genes encoding the AcrA-AcrB-TolC efflux pump in Enterobacter aerogenes and constructed acrAB and tolC mutants from a multidrug-resistant isolate. Both derivatives were more susceptible to antibiotics than the parental strain. Sequence analysis and complementation experiments revealed that the multidrug-resistant isolate is an acrR mutant.
Structure of the Acrabz-Tolc Multidrug Efflux Pump in A Drug-Bound State

Zhao Wang,Dijun Du,Guizhen Fan,Irina I. Serysheva,Ben F. Luisi,Wah Chiu

DOI: https://doi.org/10.1016/j.bpj.2015.11.108

IF: 3.4

2016-01-01

Biophysical Journal

Abstract:The capacity of numerous bacterial species to tolerate antibiotics and other toxic compounds arises in part from the activity of energy-dependent transporters. In Gram-negative species, the transporters are components of nanomachines that span the cell envelope, and a well characterized representative of such assemblies is the AcrABZ-TolC complex, a acridine resistance complex pump of Escherichia coli. The AcrABZ-TolC assembly comprises the outer-membrane channel TolC, the secondary transporter AcrB located in the inner membrane, the periplasmic AcrA which bridges these two integral membrane proteins, and a 49 amino acid residue protein, AcrZ. The entire AcrABZ-TolC complex has a molecular mass of ∼850 kDa. In E. coli, the AcrABZ-TolC pump transports vectorially chemically similar compounds thereby conferring bacterial resistance to a broad spectrum of antibiotics. In our previous study, we have determined a substrate-free structure of the entire AcrABZ-TolC pump at 16 Å resolution using single-particle cryo-EM approach (Du, Wang, et al Nature 509, 512-5, 2014). We were able to build a pseudo-atomic model of the pump utilizing available X-ray crystal structures of its components. This model defines the quaternary arrangement of the pump components and identifies key domain interaction interfaces critical for the channel assembly and opening. Recently, using single-particle cryo-EM we have resolved the structure of AcrABZ-TolC pump bound to puromycin to subnanometer resolution. The cryo-EM density map resolves the secondary structural elements of the components and clearly identifies molecular boundaries between individual components of the pump. The new structure provides insights into conformational changes that might be involved in substrate binding and transport. Further studies are being pursued to decipher the molecular mechanisms underlying assembly and function of the AcrABZ-TolC pump.
In Situ Structure and Assembly of the Multidrug Efflux Pump AcrAB-TolC.

Xiaodong Shi,Muyuan Chen,Zhili Yu,James M. Bell,Hans Wang,Isaac Forrester,Heather Villarreal,Joanita Jakana,Dijun Du,Ben F. Luisi,Steven J. Ludtke,Zhao Wang

DOI: https://doi.org/10.1038/s41467-019-10512-6

2020-01-01

Abstract:Multidrug efflux pumps actively expel a wide range of toxic substrates from the cell and play a major role in intrinsic and acquired drug resistance. In Gram-negative bacteria, these pumps form tripartite assemblies that span the cell envelope. However, the in situ structure and assembly mechanism of multidrug efflux pumps remain unknown. Here we report the in situ structure of the Escherichia coli AcrAB-TolC multidrug efflux pump obtained by electron cryo-tomography and subtomogram averaging. The fully assembled efflux pump is observed in a closed state under conditions of antibiotic challenge and in an open state in the presence of AcrB inhibitor. We also observe intermediate AcrAB complexes without TolC and discover that AcrA contacts the peptidoglycan layer of the periplasm. Our data point to a sequential assembly process in living bacteria, beginning with formation of the AcrAB subcomplex and suggest domains to target with efflux pump inhibitors.
Heterogeneous Resistance to Colistin in Enterobacter Cloacae Complex Due to a New Small Transmembrane Protein

Liang Huang,Yu Feng,Zhiyong Zong

DOI: https://doi.org/10.1093/jac/dkz236

2019-01-01

Abstract:Background: Enterobacter strains can display heterogeneous resistance (heteroresistance) to colistin but the mechanisms remain largely unknown. We investigated potential mechanisms of colistin heteroresistance in an Enterobacter clinical strain, WCHECl-1060, and found a new mechanism. Methods: Strain WCHECl-1060 was subjected to WGS to identify known colistin resistance mechanisms. Tn5 insertional mutagenesis, gene knockout and complementation and shotgun cloning were employed to investigate unknown colistin heteroresistance mechanisms. RNA sequencing was performed to link the newly identified mechanism with known ones. Results: We showed that the phoP gene [encoding part of the PhoP-PhoQ two-component system (TCS)], the dedA(Ecl) gene (encoding an inner membrane protein of the DedA family) and the tolC gene (encoding part of the AcrAB-TolC efflux pump) are required for colistin heteroresistance. We identified a new gene, ecr, encoding a 72 amino acid transmembrane protein, which was able to mediate colistin heteroresistance. We then performed RNA sequencing and transcriptome analysis and found that in the presence of ecr the expression of phoP and the arnBCADTEF operon, which synthesizes and transfers L-Ara4N to lipid A, was increased significantly. Conclusions: The small protein encoded by ecr represents a new colistin heteroresistance mechanism and is likely to mediate colistin heteroresistance via the PhoP-PhoQ TCS to act on the arnBCADTEF operon.
Deciphering the molecular and functional basis of TMexCD1: the plasmid-encoded efflux pump of resistance-nodulation-division superfamily

Yan Shang,Ye Zhang,Ruimin Wang,Yishu Peng,Bo Ding,Yuanxiang Liu,Chongzhou Li,Luhua Feng,Honglei Liu,Chunyu Yang,Yajie Tang

DOI: https://doi.org/10.1128/aac.01678-23

IF: 5.938

2024-04-03

Antimicrobial Agents and Chemotherapy

Abstract:ABSTRACT Horizontal gene transfer has been demonstrated to be an important driver for the emergency of multidrug-resistant pathogens. Recently, a transferable gene cluster tmexCD1-toprJ1 of the resistance-nodulation-division (RND) superfamily was identified in the plasmids of animal-derived Klebsiella pneumoniae strains, with a higher efflux capacity for various drugs than the Escherichia coli AcrAB-TolC homolog system. In this study, we focused on the differences in the inner membrane pump of these two systems and identified some key residues that contribute to the robust efflux activity of the TMexCD1 system. With the aid of homologous modeling and molecular docking, eight residues from the proximal binding pocket (PBP) and nine from the distal binding pocket (DBP) were selected and subjected to site-directed mutagenesis. Several of them, such as S134, I139, D181, and A290, were shown to be important for substrate binding in the DBP region, and all residues in PBP and DBP showed certain substrate preferences. Apart from the conservative switch loop (L613–623 TMexD1 ) previously identified in the E. coli AcrB (EcAcrB), a relatively unconservative loop (L665–675 TMexD1 ) at the bottom of PBP was proposed as a critical element for the robust activity of TMexD1, due to variations at sites E669, G670, N673, and S674 compared to EcAcrAB, and the significantly altered efflux activity due to their mutations. The conservation and flexibility of these key factors can contribute to the evolution of the RND efflux pumps and thus serve as potential targets for developing inhibitors to block the widespread of the TMexCD1 system.

pharmacology & pharmacy,microbiology
Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Escherichia coli

Rawaf Alenazy

DOI: https://doi.org/10.3390/biology11091328

2022-09-09

Biology

Abstract:Infections caused by multidrug resistance (MDR) of Gram-negative bacteria have become one of the most severe public health problems worldwide. The main mechanism that confers MDR to bacteria is drug efflux pumps, as they expel a wide range of compounds, especially antibiotics. Among the different types of drug efflux pumps, the resistance nodulation division (RND) superfamily confers MDR to various Gram-negative bacteria species. The AcrAB-TolC multidrug efflux pump, from E. coli, a member of RND, is the best-characterized example and an excellent model for understanding MDR because of an abundance of functional and structural data. Small molecule inhibitors that target the AcrAB-TolC drug efflux pump represent a new solution to reversing MDR in Gram-negative bacteria and restoring the efficacy of various used drugs that are clinically relevant to these pathogens, especially in the high shortage of drugs for multidrug-resistant Gram-negative bacteria. This review will investigate solutions of MDR in Gram-negative bacteria by studying the inhibition of the AcrAB-TolC multidrug efflux pump.

biology

Toward a Feminist Critical Pedagogy in a Beginning Japanese-as-a-Foreign-Language Class

Evaluation and Target Validation of Indole Derivatives As Inhibitors of the AcrAB-TolC Efflux Pump.

Elucidating TolC Protein Dynamics: Structural Shifts Facilitate Efflux Mediated β-lactam Resistance

Physiological Effects of TolC‐Dependent Multidrug Efflux Pumps in Escherichia coli: Impact on Motility and Growth Under Stress Conditions

AcrA suppressor alterations reverse the drug hypersensitivity phenotype of a TolC mutant by inducing TolC aperture opening

Tigecycline Susceptibility And The Role Of Efflux Pumps In Tigecycline Resistance In Kpc-Producing Klebsiella Pneumoniae

The Antibiotic Efflux Protein TolC Is a Highly Evolvable Target under Colicin E1 or TLS Phage Selection

Structural shifts in TolC facilitate Efflux-Mediated β-lactam resistance

Efflux Pump AcrAB Confers Decreased Susceptibility to Piperacillin-Tazobactam and Ceftolozane-Tazobactam in Tigecycline-Non-Susceptible Klebsiella Pneumoniae

Escherichia coli resistance mechanism AcrAB-TolC efflux pump interactions with commonly used antibiotics: a molecular dynamics study

Functional characterization of two TolC in the resistance to drugs and metals and in the virulence of Riemerella anatipestifer

Structures and Efflux Mechanisms of the AcrAB-TolC Pump

Structure of the AcrAB–TolC Multidrug Efflux Pump

Required criteria of drug efflux pump inhibitors to disrupt the function of AcrB subunit protein from AcrAB-TolC multidrug efflux pump from Escherichia coli

In situ structure of the AcrAB-TolC efflux pump at subnanometer resolution

The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes

Structure of the Acrabz-Tolc Multidrug Efflux Pump in A Drug-Bound State

In Situ Structure and Assembly of the Multidrug Efflux Pump AcrAB-TolC.

Heterogeneous Resistance to Colistin in Enterobacter Cloacae Complex Due to a New Small Transmembrane Protein

Deciphering the molecular and functional basis of TMexCD1: the plasmid-encoded efflux pump of resistance-nodulation-division superfamily

Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Escherichia coli